title: Review of liraglutide versus sitagliptin for patients with uncontrolled type 2 diabetes: more effective HbA 1c reduction with subcutaneous GLP-1 receptor agonist versus an oral DPP-4 inhibitor.
authors.affiliation: HealthReach Diabetes Endocrine Nutrition Center, 881 Lafayette Rd., Hampton, NH 03842, USA. dnadeaumd@gmail.com
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Nadeau